1. Home
  2. VLRS vs ELVN Comparison

VLRS vs ELVN Comparison

Compare VLRS & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLRS
  • ELVN
  • Stock Information
  • Founded
  • VLRS 2005
  • ELVN 2016
  • Country
  • VLRS Mexico
  • ELVN United States
  • Employees
  • VLRS N/A
  • ELVN N/A
  • Industry
  • VLRS Air Freight/Delivery Services
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLRS Consumer Discretionary
  • ELVN Health Care
  • Exchange
  • VLRS Nasdaq
  • ELVN Nasdaq
  • Market Cap
  • VLRS 951.9M
  • ELVN 1.1B
  • IPO Year
  • VLRS N/A
  • ELVN 2020
  • Fundamental
  • Price
  • VLRS $7.76
  • ELVN $21.80
  • Analyst Decision
  • VLRS Strong Buy
  • ELVN Strong Buy
  • Analyst Count
  • VLRS 6
  • ELVN 5
  • Target Price
  • VLRS $13.33
  • ELVN $37.80
  • AVG Volume (30 Days)
  • VLRS 570.8K
  • ELVN 227.8K
  • Earning Date
  • VLRS 02-28-2025
  • ELVN 03-13-2025
  • Dividend Yield
  • VLRS N/A
  • ELVN N/A
  • EPS Growth
  • VLRS N/A
  • ELVN N/A
  • EPS
  • VLRS 0.16
  • ELVN N/A
  • Revenue
  • VLRS $3,205,478,000.00
  • ELVN N/A
  • Revenue This Year
  • VLRS N/A
  • ELVN N/A
  • Revenue Next Year
  • VLRS $6.71
  • ELVN N/A
  • P/E Ratio
  • VLRS $4.69
  • ELVN N/A
  • Revenue Growth
  • VLRS 0.78
  • ELVN N/A
  • 52 Week Low
  • VLRS $5.15
  • ELVN $10.90
  • 52 Week High
  • VLRS $9.57
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • VLRS 42.44
  • ELVN 48.03
  • Support Level
  • VLRS $7.63
  • ELVN $21.16
  • Resistance Level
  • VLRS $8.60
  • ELVN $22.91
  • Average True Range (ATR)
  • VLRS 0.34
  • ELVN 1.00
  • MACD
  • VLRS -0.01
  • ELVN 0.06
  • Stochastic Oscillator
  • VLRS 12.89
  • ELVN 45.02

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central and South America. It currently operates up to 500 average daily flight segments on routes that connect 44 cities in Mexico as well as 22 cities in the United States, four in Central America and two in South America. It uses promotional fares to stimulate demand and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires at the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger revenues and cargo services.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

Share on Social Networks: